Kathleen Fernandes Grego
Papers
1
Total Citations
7
H-Index
1
About
Kathleen Fernandes Grego is a leading researcher in toxinology, with a primary focus on the biochemical and pharmacological mechanisms of snake venoms and their inhibitors. Her most notable contribution is the discovery and characterization of BoaγPLI, a phospholipase A2 inhibitor derived from the blood of the Boa constrictor. This work, published in 2021, demonstrated that BoaγPLI acts as a broad-spectrum inhibitor, effectively neutralizing the pathophysiological actions of venom PLA2 from various snake species. With 7 citations, this study has already garnered attention for its potential applications in developing novel antivenom therapies and understanding evolutionary adaptations in snakes. Grego’s research bridges fundamental biochemistry and translational medicine, offering insights into how natural inhibitors can mitigate venom-induced tissue damage, inflammation, and coagulation disorders. Her work is particularly impactful for researchers in herpetology, pharmacology, and emergency medicine, as it highlights a promising avenue for improving snakebite treatments. Through her meticulous investigations, Grego continues to advance our understanding of venom–inhibitor interactions, positioning her as a key figure in the quest for more effective and accessible antivenoms.
Research Focus
Key Achievements
Top Papers
- 1